ARZNEIMITTELABGABEVORRICHTUNG

European patent · EP3669913 · In force

Register entry

Publication number
EP3669913
Application number
EP20157230
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 29, 2013
Published
Jun 24, 2020
Granted
Nov 6, 2024
Protection ends at the latest
Aug 28, 2033
Next annual fee due
Aug 31, 2027
IPC classes
A61M 5/315 (2006.01)
A61M 5/24 (2006.01)
A61M 5/31 (2006.01)
Priority
EP 12182568 31.08.2012
US 201261697078 P 05.09.2012
Divided from
EP13756118
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. Sep 17, 2025

    Change

    Published in Swissreg on 17.09.2025

  3. Sep 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.08.2025 → 31.08.2026

    Published in Swissreg on 01.09.2025

  4. Nov 6, 2024

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 06.11.2024

Parties

Holder

Sanofi-Aventis Deutschland GmbH

Brüningstraße 50, 65929 Frankfurt am Main, DE

Inventor

PLUMPTRE, David Aubrey

Warwick CV34 4AB, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.